Y-mAbs Therapeutics Overview

Life ScienceCompany

Was Y-mAbs Therapeutics formerly PE-backed?

Yes. Y-mAbs Therapeutics was formerly owned by 1 private investor.

Where is Y-mAbs Therapeutics headquartered?

Y-mAbs Therapeutics is headquartered in Princeton, New Jersey.

What is Y-mAbs Therapeutics’ revenue?

Y-mAbs Therapeutics disclosed revenue of 88M USD for 2024 and 85M USD for 2023.

What sector is Y-mAbs Therapeutics in?

Y-mAbs Therapeutics is a life science company.

When was Y-mAbs Therapeutics founded?

Y-mAbs Therapeutics was founded in 2015.

Y-mAbs Therapeutics

Y-mAbs Therapeutics, Inc.

202 Carnegie Center, Suite 301,
Princeton, New Jersey 08540
United States,
(646) 885-8505
www.ymabs.com

Y-mAbs Therapeutics is a commercial-stage clinical biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. With a broad and advanced product pipeline, including pivotal-stage product candidates against a range of targets. Y-mAbs Therapeutics was founded in 2015 and is based in Princeton, New Jersey.



Try Mergr Free — See This and 220,453+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 82K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.